Hedge Fund News: Warren Buffett, Phil Falcone & Baupost Group
It must have been a bitter moment for President Barack Obama when he got the news that his favorite economic guru not only doesn’t like paying taxes but hates America.
Posts Tagged ‘NYSE:MRK’
Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
How Pharma Majors like Pfizer Inc. (PFE), Johnson & Johnson (JNJ) And Merck & Co. Inc. (MRK) Are Responding To Alzheimer?
CNBC's Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions...
Beech Hill Partners Top Five Holdings at the End of March
Beech Hill Partners, led by Paul Cantor, Joseph Weiss, and Will Wurm, is a traditional boutique fund that was established as a privately owned investment advisory arm of Beech...
5 Mid-Cap Stocks That Insiders Love
Recent research conducted at InsiderMonkey has shown that stocks bought by insiders tend to outperform market indexes.
Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Activist Alex Denner’s Sarissa Capital Bets on Ariad Pharmaceuticals Inc (ARIA), Quest Diagnostics Inc (DGX) & Others
Alex Denner’s Sarissa Capital disclosed its holdings in its latest and first 13F filings.
Merck Restructuring Takes Hold
Merck restructuring: On Tuesday, Merck & Co., Inc. (NYSE:MRK) announced that it will fire 8,500 workers.
The Pharmaceutical Industry’s 10 Biggest R&D Budgets
Innovation is everything when it comes to the pharmaceutical sector.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal
Through the years, London-based drugmaker AstraZeneca plc (ADR) (NYSE:AZN) and U.S. pharmaceutical firm Merck & Co., Inc.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Johnson & Johnson (JNJ): Top Risk Factors for Heart Disease
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger on a $500 million deal...
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK), Rockwell Medical Inc (RMTI): Three Drug Classes That May Become Obsolete Within Three Years
There are few, if any, businesses in the world where innovation isn't the top priority.
Merck & Co., Inc. (MRK), Akamai Technologies, Inc. (AKAM), Cyberonics, Inc. (CYBX): Next Leaders in Technology and Health Care
In an unusual divergence, stocks belonging to the defensive health care and cyclical technology spaces delivered some of the best responses to earnings last quarter .
Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK): Everyone Wants a Piece of This Mega-Blockbuster
According to a recent Bloomberg report, Gilead Sciences, Inc.
AT&T Inc. (T), Verizon Communications Inc. (VZ): Are the Dogs of the Dow (.DJI) Still in the Race?
The Dogs of the Dow strategy involve investing equal amounts into the 10 highest-yielding dividend stocks on the Dow Jones Industrial Average 2 Minute (INDEXDJX:.DJI).
Do Hedge Funds and Insiders Love AstraZeneca plc (ADR) (AZN)?
At the moment, there are dozens of gauges investors can use to track Mr. Market. A pair of the most under-the-radar are hedge fund and insider trading movement.
Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits
Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...
This Metric Says You Are Smart to Buy GlaxoSmithKline plc (ADR) (GSK)
In the financial world, there are many methods market participants can use to track the equity markets.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Two Reasons This Biotech Hardly Moved After a Successful Trial
Adding Esperion Therapeutics' ECT-1002 to Pfizer Inc. (NYSE:PFE)'s Lipitor lowered bad LDL cholesterol levels by 22%.
Eli Lilly & Co. (LLY), Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK): Where We’re Headed
Over the past couple of months we've discussed many of the biggest risk factors associated with some of the leading causes of death in the United States -- heart disease, cancer...
GlaxoSmithKline plc (GSK), Merck & Co. Inc. (MRK): HPV Vaccine for Boys Has “Good Start” in 1st Year
ATLANTA (AP) -- When the HPV vaccine was first recommended for boys, health officials worried it would be an unusually hard sell.
AbbVie Inc (ABBV): Are Hedge Funds Right About This Stock?
Now, according to many investors, hedge funds are seen as overrated, outdated investment tools of a period lost to current times.
Tyson Foods, Inc. (TSN), Merck & Co., Inc. (MRK): Food Companies Suspend Growth Meds for Animals
Top beef producer Tyson Foods, Inc. (NYSE:TSN) has decided to stop buying cattle that are fed the growth additive Zilmax, produced by Merck & Co., Inc. (NYSE:MRK).
Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health
In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets.
Hedge Funds Are Buying Novartis AG (ADR) (NVS)
In the 21st century investor’s toolkit, there are dozens of methods market participants can use to monitor the equity markets.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Tyson Foods, Inc. (TSN), Smithfield Foods, Inc. (SFD): Merck & Co., Inc. (MRK) Buried by Industry Beef
Like a pebble rolling downhill and starting an avalanche, the decision by Tyson Foods, Inc.
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Which Pharmaceutical Giant Faces the Steepest Patent Cliff?
At the same time, the pharmaceutical industry isn't without its share of risks.
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player
Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab.
Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors.
Merck & Co., Inc. (MRK), Sony Corporation (ADR) (SNE): How the Dow Jones Industrial Average (.DJI)’s Oldest Company Got Started
The Dow Jones Industrial Average (INDEXDJX:.DJI) has 30 components, and all but one can trace their origins to a company founded in the United States after the American Revolution...
Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK): The Past, Present, and Future of HIV Treatments
HIV, the virus that causes AIDS, has become one of the world's most devastating diseases since it was first recognized more than three decades ago.
The Medicines Company (MDCO), Merck & Co., Inc. (MRK), Baxter International Inc. (BAX): Three Reasons to Like This Critical Care Company
The Medicines Company (NASDAQ:MDCO) is a mid-cap value stock that jumped by 21% in the last 12 months, trading at a 52-week price range of $20.04-$37.40.
Is Sanofi SA (ADR) (SNY) Going to Burn These Hedge Funds?
To the average investor, there are plenty of gauges investors can use to track Mr. Market. Some of the most useful are hedge fund and insider trading interest.
Hedge Funds Are Buying Bristol Myers Squibb Co. (BMY)
In the eyes of many of your peers, hedge funds are perceived as useless, outdated financial tools of a forgotten age.
Someone’s Selling Pfizer Inc. (PFE) Shares, Should You?
Now, according to many traders, hedge funds are seen as delayed, outdated investment tools of an era lost to time.
Dendreon Corporation (DNDN), Vertex Pharmaceuticals Incorporated (VRTX): The Rise and Fall of the Fastest Growing Drug in the World
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Novo Nordisk A/S (ADR) (NVO), Dynavax Technologies Corporation (DVAX), Merck & Co., Inc. (MRK): Three Biggest FDA Rejections This Year (So Far)
At least the Food and Drug Administration is polite.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Alarming New Obesity Data Points to a Scary Trend
Last week, the Trust for America's Health and the Robert Wood Johnson Foundation released their annual report (link opens a PDF to a 116-page report) on obesity trends in the ...
Paul Tudor Jones Is Trading LyondellBasell Industries NV (LYB), Baxter International Inc. (BAX) & Merck & Co., Inc. (MRK)
Paul Tudor Jones is the manager of Tudor Investment Corp, focusing on equity, debt, venture capital, currency and the commodity markets.
MannKind Corporation (MNKD): What’s the Latest: New Insulin Inhaler, Rating Reiterated by Zacks, Matthew J. Pfeffer & More
The long promise of insulin that diabetics can inhale appears to be moving closer to the market.
A Smart Eli Lilly & Co. (LLY) Investor Does What Now?
Eli Lilly & Co. (NYSE:LLY) was in 35 hedge funds' portfolio at the end of March. LLY investors should be aware of a decrease in hedge fund interest recently.
Merck & Co., Inc. (MRK), Novartis AG (ADR) (NVS): One Hidden Pharmaceutical Technology for Your Portfolio
Pharmaceutical companies are always looking for competitive advantages.
Sanofi SA (ADR) (SNY), Merck & Co., Inc. (MRK): Healthier Days Loom as 3 Big Pharmas Move on Dengue Shots
Mosquito bites sure suck, literally and figuratively. But more so if these are delivered by the insects’ female species, which cause viral infections. But forget malaria.
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)'s extended phase 3 program for its inhaled insulin, Afrezza, is likely to produce ...
